These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2583843)

  • 1. Collection and transfusion of single donor platelets and their clinical response.
    Hester J; Ventura G
    Infusionstherapie; 1989 Aug; 16 Suppl 2():4-9; discussion 28-9. PubMed ID: 2583843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion results of cytapheresis platelet concentrates stored in two different polyolefin containers for five days.
    Arseniev L; Weisswange T; Neumann HJ; Stangel W
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):274-7. PubMed ID: 7950292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation and use of thrombocyte and leukocyte concentrates].
    Kalinin NN
    Probl Gematol Pereliv Krovi; 1980 Oct; 25(10):50. PubMed ID: 6999495
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.
    Goodnough LT; Kuter DJ; McCullough J; Slichter SJ; DiPersio J; Romo J; Peterson R; Smith KJ; Raife T; Tomita D; Armstrong S
    Blood; 2001 Sep; 98(5):1346-51. PubMed ID: 11520781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of a freshly prepared thrombocyte mass in thrombocytopenic hemorrhages].
    Baĭdurin SA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):33-9. PubMed ID: 7367409
    [No Abstract]   [Full Text] [Related]  

  • 6. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparison of the therapeutic effectiveness of thrombocytapheresis concentrates and platelet concentrates isolated from whole body stores].
    Adamzik I; Hühn A; Dörner R; Sachs V
    Beitr Infusionsther; 1988; 21():100-2. PubMed ID: 2462952
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase in platelet count is not affected by the platelet yield of single donor pheresed platelets.
    Moser DW; Mackley AB; Hays J; Paul DA
    J Pediatr Hematol Oncol; 2007 May; 29(5):315-8. PubMed ID: 17483709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of treatment with platelet concentrates.
    Lanzer G
    Acta Anaesthesiol Scand Suppl; 1996; 109():141-3. PubMed ID: 8901986
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous-flow techniques for platelet concentrate collection: a step toward standardization and yield predictability.
    Hester JP; Kellogg RM; Mulzet AP; Freireich EJ
    J Clin Apher; 1985; 2(3):224-30. PubMed ID: 4030710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresis.
    Daly PA; Schiffer CA; Aisner J; Wiernik PH
    Transfusion; 1979; 19(6):778-81. PubMed ID: 524435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which are the parameters to be controlled in platelet concentrates in order that they may be offered to the medical profession as a standardized product with specific properties?
    Vox Sang; 1981 Feb; 40(2):115-26. PubMed ID: 7233883
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
    Gubanova MN; Ayupova RF; Zhiburt EB
    Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serial platelet counts following massive blood transfusion in pediatric patients.
    Coté CJ; Liu LM; Szyfelbein SK; Goudsouzian NG; Daniels AL
    Anesthesiology; 1985 Feb; 62(2):197-201. PubMed ID: 3970376
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
    Lee EJ; Schiffer CA
    Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.